Head and neck cancer trials in China

In China 216 Also abroad 944

216 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 2Not yet taking people in China
Neoadjuvant Presurgical Becotatug Vedotin (MRG003) Plus Pucotenlimab (HX008) in Oral Cavity Squamous Cell Carcinoma
Where
Guangzhou
Age
18 years to 70 years
People
32
Run by
Sun Yat-sen University
See details and how to joinNCT07766889
Phase 2Not yet taking people in China
Penpulimab Combined With Chemotherapy for Patients With Locally Advanced Hypopharyngeal Carcinoma
Where
Xi’an
Age
18 years to 80 years
People
15
Run by
Tang-Du Hospital
See details and how to joinNCT07752394
Phase 2Not yet taking people in China
MRG003 Plus Toripalimab Versus Toripalimab as Neoadjuvant Therapy for PD-L1-Positive, Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma
Where
Dongguan
Age
18 years to 70 years
People
65
Run by
Dongguan People's Hospital
See details and how to joinNCT07677475
No phaseNot yet taking people in China
Discovery and Validation of Biomarkers for Periodontitis, Dental Caries and Oral Squamous Cell Carcinoma
Where
Shanghai
Age
18 years and over
People
4,000
Run by
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
See details and how to joinNCT07745803
No phaseTaking people
SGRT in Head and Neck Cancer Radiotherapy
Where
Guangzhou
Age
18 years to 75 years
People
40
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07726407
Phase 2Taking people
A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
Where
Shanghai
Age
18 years to 75 years
People
46
Run by
Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT06437522
Phase 1Taking people
Study of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid Tumors
Where
Tianjin
Age
18 years and over
People
493
Run by
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
See details and how to joinNCT07589205
Phase 1Taking people
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Where
Beijing, Shanghai
Age
18 years and over
People
714 worldwide
Run by
Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00
Phase 2Taking people
Tislelizumab Combined With Chemotherapy for Different Cycles of Neoadjuvant Therapy for Locally Advanced Resectable Squamous Cell Carcinoma of the Head and Neck (NeoTempo)
Where
Tianjin
Age
18 years and over
People
100
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07147426
Phase 1/2Taking people
A Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead and Neck Squamous Cell Carcinoma Cancer
Where
Chengdu, Chongqing
Age
18 years to 75 years
People
210
Run by
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT07059221
No phaseEnrolling by invitation
A Bidirectional Study of Individualized Postoperative Adjuvant Treatment Decision Model for Locally Advanced Head and Neck Squamous Cell Carcinoma Based on Multimodal Dynamic Data
Where
Guangzhou
Age
18 years and over
People
571
Run by
Nanfang Hospital, Southern Medical University
See details and how to joinNCT07532928
No phaseNot yet taking people in China
Effects of a Perma-h Model Mobile-based Rehabilitation Support Program on Hope, Self-efficacy, Perceived Social Support and Rehabilitation Outcomes in Post- Tracheostomy Oral Cancer Patients
Where
Haikou
Age
18 years and over
People
100 worldwide
Run by
Hainan Medical College
See details and how to joinNCT07714967
Phase 2Taking people
H101 Plus TACE for r/m HNSCC
Where
Chengdu
Age
18 years to 80 years
People
20
Run by
West China Hospital
See details and how to joinNCT07398664
Phase 2Taking people
Neoadjuvant EGFR-ADC Combined With Anti-PD-1 Monoclonal Antibody in Resectable Locally Advanced Hypopharyngeal Squamous Cell Carcinoma
Where
Tianjin
Age
18 years and over
People
52
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07665190
Phase 2Not yet taking people in China
A Prospective, Exploratory Study of Becotatug Vedotin Plus Putlimab for Neoadjuvant Therapy and Adjuvant Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
Where
Nanjing
Age
18 years to 75 years
People
35
Run by
Jiangsu Cancer Institute & Hospital
See details and how to joinNCT07707167
Phase 2Taking people
Pucotenlimab Plus Becotatug Vedotin in Perioperative Treatment of Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma
Where
Beijing, Changsha, Fuzhou, Guangzhou, Hangzhou, Nanning, Ningbo, Shanghai, Shantou, Shenyang, Shijiazhuang, Wuhan
Age
18 years and over
People
80
Run by
Lepu Biopharma Co., Ltd.
See details and how to joinNCT07586124
Phase 2Taking people
Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
Where
Shanghai
Age
18 years to 75 years
People
182
Run by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07601737
Phase 1Taking people
Clinical Study of CFH Protein Via Ice Microneedles for Radiation-Induced Skin Fibrosis
Where
Chengdu
Age
18 years to 75 years
People
9
Run by
West China Hospital
See details and how to joinNCT07567235
Phase 1/2Taking people
Camrelizumab With Famitinib for Patients With Rare Head and Neck Malignancies
Where
Shanghai
Age
18 years and over
People
40
Run by
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
See details and how to joinNCT07662681
Phase 2Taking people
Efficacy and Safety of Paclitaxel Polymeric Micelles in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Where
Shanghai
Age
18 years to 75 years
People
29
Run by
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
See details and how to joinNCT07662746
Phase 2Taking people
Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCC
Where
Shanghai
Age
18 years to 75 years
People
39
Run by
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
See details and how to joinNCT07088211
Phase 2Taking people
Iparomlimab and Tuvonralimab in HNSCC
Where
Shanghai
Age
18 years to 75 years
People
30
Run by
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
See details and how to joinNCT07090317
Phase 2Not yet taking people in China
A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.
Where
Beijing, Harbin
Age
18 years to 80 years
People
227
Run by
GV20 Therapeutics
See details and how to joinNCT07623642
Phase 2Taking people
Becotatug Vedotin Combined With Pucotenlimab for Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma
Where
Shanghai
Age
18 years to 75 years
People
102
Run by
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
See details and how to joinNCT07632339
No phaseTaking people
Specialist Nurse-Led Nursing Management for Patients Undergoing Head and Neck Cancer Surgery
Where
Tianjin
Age
18 years to 70 years
People
80
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07622381